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Gregory L. Moneta, MD, Section EditorDiagnosis and Surgical Treatment of Nutcracker Syndrome: A Single-
Center Experience
Wang L, Yang L, Lui Z, et al. Urology 2009;73:871-6.
Conclusion: Left renal vein transposition is an efficient surgical treat-
ment for nutcracker syndrome. In some cases however pelvic pain remains
following left renal vein transposition.
Summary: The nutcracker syndrome is an unusual problem where
the left renal vein is narrowed as it passes between an angle formed
between the abdominal aorta and the superior mesenteric artery. This
narrowing of the left renal vein can lead to increase venous pressure
within the renal circulation and promote development of varices of the
renal pelvis and ureter with resulting hematuria. Other symptoms asso-
ciated with nutcracker syndrome include orthostatic proteinuria, flank
pain, left-sided varicocele, pelvic congestion, and chronic fatigue. The
authors retrospectively reviewed 23 patients with the diagnosis of nut-
cracker syndrome treated at their institution from July 1998 to July
2007. Nutcracker syndrome was suspected based on the combination of
clinical examination, ultrasound, CT imaging, and MRI imaging. Hema-
turia was the most common presenting symptom (21 of 23 patients). One
patient presented with orthostatic proteinuria and 1 with pelvic conges-
tion syndrome. No patient had renal function deterioration and 13 of 23
undergoing cystoscopy had bleeding noted from the left ureteral orifice.
Only 7 underwent transposition of the left renal vein with the indication
of transposition being recurrent gross hematuria in 6 patients and
persistent orthostatic proteinuria in 1 patient. Sixteen patients who had
more mild symptoms were followed without operation. Patients with
microscopic hematuria or intermittent short periods of painless gross
hematuria were followed closely without treatment. Patients with flank
or abdominal pain were treated with low-dose aspirin treatment. Four
women with pelvic congestion syndrome were treated with medroxypro-
gesterone acetate.
Patients undergoing left renal vein transposition did so through a
mid-line abdominal incision with mobilization of the left colon and small
bowel to give access to the retroperitoneum. The inferior adrenal vein,
ovarian/testicular vein, and the lumbar vein draining into the left renal vein
were ligated and transected. The left renal vein was excised with the small rim
of vena cava and injected with heparin. Reanastomosis was then performed
to a more caudad portion of the inferior vena cava. All 7 patients treated with
renal vein transposition had normal pre-operative creatinine levels with no
increase following renal vein transposition. Hematuria and proteinuria
ceased spontaneously 5 to 14 days following surgery with no clinical relapses.
Of the 16 patients treated conservatively, clinical improvement occurred in
11 with total relief of symptoms in 2 patients and partial relief in 9 patients.
There was no relief of symptoms in 5 patients following a mean follow-up of
41.2 months.
Comment: The pressure gradient between the left renal vein near the
renal hilum is normally between 0 and 1 mmHg (J Urology 1982; 127:
1070-1071). An elevated gradient of more than 3 mmHg between the left
renal vein and the vena cava is used as a criteria to diagnose nutcracker
syndrome. All patients in this series had such a gradient. The study indicates
that left renal vein transposition works well to alleviate symptoms in patients
with nutcracker syndrome and elevated renal vein IVC pressure gradients.
Equally important is that patients with mild symptoms do well treated
conservatively. It would appear reasonable to reserve surgical treatment of
nutcracker syndrome to those patients with recurrent gross hematuria or
persistent orthostatic proteinuria who are not responsive to conservative
management. The authors also point out that children and adolescents can
have nutcracker syndrome that will frequently resolve as the child matures
into adulthood. Surgical treatment of nutcracker syndrome in children and
adolescents therefore, in most cases, should be avoided.
Endovascular Treatment of Type B Aortic Dissection: The Challenge of
Late Success
Rodrigues Alves CM, Palma da Fonseca JH, Marcondes de Souza JA, et al.
Ann Thorac Surg 2009;87:1360-5.
Conclusions: Following endovascular thoracic aortic repair, patients
with both acute and chronic type B aortic dissections have excellent initial
results. Frequent need for new interventions leads to a steady decline in
event-free survival rates, but overall survival curves are comparable in pa-
tients with type B dissection undergoing less complex surgical or medical
treatment.Summary: There is a trend towards liberalization of the use of TEVAR
for treatment of type B aortic dissection. From 1997-2004 the authors
1526treated 106 patients with complicated or symptomatic type B aortic dissec-
tion with thoracic endografts. In the 106 patients treated technical success
was obtained in 105, and clinical success in 88 (83%). The left subclavian
artery was covered in 24 cases. Two required subsequent elective left upper
extremity revascularization. Six patients required surgical conversion within
3 days. Five patients died within 30 days (4.7%), 2 from complications of
surgical conversion, 2 from rupture (1 rupture was in a patient with technical
success of TEVAR placement), and 1 died after an extensive CVA. Patients
treated for urgent conditions had a higher in-hospital mortality than those
treated for chronic conditions (18.7% vs. 2.2%, p0.02). There were 3
strokes, 1 case of paraplegia, and 1 case of paraparesis. Three patients had
peripheral vascular complications and there were 4 cases of acute renal
failure.
There were 84 patients discharged from the hospital with clinical
success and follow-up was obtained in 73. Average duration of follow-up in
these 73 patients was 35.9  28.5 months. In the 73 patients with late
follow-up, late failure of the TEVAR procedure was observed in 37%. There
were 8 late deaths due to aortic causes. There was only 1 patient with a type
A dissection that occurred late.
Comment: The most telling information here is the high rate of late
failure (37%). The Braile stent graft was implanted in this study. This graft is
not approved for use in the U.S. The explanation for late failure is unclear.
Some may be related to the type of graft implanted, the technique of graft
implantation (many patients early in this series were treated with only a short
graft if treated acutely), or it may relate to the fact that the aortic wall is
diffusely fragile in patients with aortic dissection. It is quite clear placement
of a thoracic stent graft in a patient with a type B aortic dissection, despite
good technical results, does not return the patient to a normal survival curve
or give them freedom from late aortic related complications. We are going to
need better data with more complete follow-up using FDA approved devices
to determine whether treatment of type B aortic dissection with TEVAR is
more than just a good idea and that it actually provides true clinical benefit.
Exposure to Low-Dose Ionizing Radiation from Medical Imaging
Procedures
Fazel R, Krumholz HM, Wang Y, et al. N Engl J Med 2009;361:849-57.
Conclusion: Medical imaging procedures are an important source of
exposure to ionizing radiation. They can result in high cumulative effective
doses of radiation.
Summary: Experimental and epidemiologic evidence link exposure to
low-dose ionizing radiation with the development of both leukemia and
solid cancers (National Research Council, Health Risks from Exposure to
Low-Levels of Ionizing Radiation Beir VII Phase 2 Washington D.C.
National Academics Press 2006). Individuals at risk for repeated radiation
exposure such as workers in the nuclear and healthcare industry are moni-
tored for radiation dose and restricted to effective dose of 0.1 mSv every 5
years with a maximum of 50 mSv allowed in any given year. There is,
however, little monitoring of cumulative radiation doses for those undergo-
ing medical imaging procedures. In this study, the authors analyze recent
data on the use of imaging from 5 healthcare markets across the United
States to estimate total effective dose of radiation from medical imaging
procedures. They identified 952,420 non-elderly adults (between 18-64
years of age) in the 5 healthcare markets between January 1, 2005 and
December 31, 2007. They used utilization data to estimate cumulative
effective doses of radiation for imaging procedures. Population-based rates
of exposure were calculated. The author’s defined annual effective radiation
dose as low when the dose was  3 mSv. Moderate-doses were defined as
between 3 and 20 mSv and high-doses as 20 to 50 mSv with very high-doses
50 mSv.
During the study period 68.8% of the identified adults (n655,613)
underwent at least 1 imaging procedure involving radiation exposure. Mean
cumulative effective radiation dose from imaging procedures was 2.46.0
mSv per enrollee per year. Moderate effective doses of radiation were
incurred in 193.8 enrollees per 1,000 per year whereas high and very-high
doses were incurred in 18.6 and 1.9 enrollees per 1,000 per year respectively.
Advancing age and female sex were associated with increased cumulative
effective doses of radiation. CT scanning and nuclear imaging accounted for
75.4% of cumulative effective doses and 81.8% of the total administrative
radiation dose was administered in an outpatient setting.
Comment: A CT angiogram of the chest results in an average effective
dose of 15 mSv while plain CTs of the chest, abdomen, or pelvis average
approximately 7 mSv. A single CTA of the abdomen and pelvis in apatient
with an aortic stent graft per year immediately places that patient into the
moderate annual effective dose of radiation. One additional CT scan will
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dose of radiation. Diagnostic cardiac catheterization has an average effective
dose of 7 mSv and a percutanous coronary intervention an average of effect
of 15 mSv. It is obvious vascular surgical patients may be among those most
intensively exposed to radiation through medical imaging procedures.
Fluvastatin and Perioperative Events in Patients Undergoing Vascular
Surgery
Schouten O, Boersma E, Hoeks SE and the Dutch Echocardiographic
Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
N Engl J Med 2009;361:980-9.
Conclusion: Perioperative fluvastatin therapy is associated with an
improvement in post-operative cardiac outcome in patients undergoing
vascular surgery.
Summary: To investigate the effects of statin medications on patients
undergoing vascular surgery the authors conducted the Dutch Echocardio-
graphic Cardiac Risk Evaluation Applying Stress Echocardiography III trial
(DECREASE III). The hypothesis was that perioperative statin therapy
would reduce post-operative incidents of cardiac events in patients under-
going elective vascular surgery.
This was a double blind placebo controlled trial where patients not
previously treated with a statin were, in addition to a beta blocker, random-
ized to either 80 mg of extended-release fluvastatin, or placebo, once daily
prior to undergoing vascular surgery. Lipid levels, interleukin-6 levels, and
C-reactive protein were measured at randomization, before surgery and in
follow-up. The primary endpoint was the occurrence of myocardial ischemia
defined as a release of troponin-T, transient electrocardiographic abnormal-
ities, or both, within 30 days of surgery. Secondary endpoint was a compos-
ite of death from cardiovascular causes and myocardial infarction.
There were 250 patients assigned to the fluvastatin group and 247 to
the placebo group. Randomization was a median of 37 days before vascular
surgery. In the fluvastatin group levels of low-density lipoprotein choles-
terol, total cholesterol, C-reactive protein and interleukin-6 were signifi-
cantly reduced but were unchanged in the placebo group. Myocardial
ischemia postoperatively occurred in 27 patients (10.8%) of the fluvastatin
group, and 47 patients (19.0%) of the placebo group (hazard ratio 0.55; 95%
CI, 0.34 to 0.88; p0.01). Death from myocardial infarction or cardiovas-
cular causes occurred in 12 patients (4.8%) in the fluvastatin group and in 25
patients (10.1% in the placebo group (hazard ratio, 0.47; 95% CI, 0.24 to
0.94; p0.03). There was no increase in adverse events in the fluvastatin
group compared to the placebo.
Comment: This paper provides the strongest evidence to date of the
benefits of statin therapy in patients undergoing vascular surgery. Statins
were beneficial in patients undergoing carotid endarterectomy, lower ex-
tremity revascularization and in patients undergoing both open and endo-
vascular aortic surgery. For several years vascular surgeons have thought that
whenever possible their patients should be on a statin medication prior to
operation. The type of medication and dosage was unknown. The current
study provides us at least some guidelines for one particular drug and one
particular dosage for patients undergoing primarily elective vascular surgery.
We still need additional data as to the minimal time preoperatively that
patients can be treated with statins to achieve what appears to be a plaque
stabilization effect.
High-Dose B Vitamin Supplementation and Progression of Subclinical
Atherosclerosis: A Randomized Controlled Trial
Hodis HN, Mack WJ, Dustin L, the BVAIT Research Group. Stroke
2009;40:730-6.
Conclusion: Dietary supplementation with high-dose B vitamins re-
duces progression of carotid intima media thickness in individuals with a
fasting total homocysteine  9.1 mol/L and who are at low risk for
cardiovascular disease.
Summary:Bothmeta-analysis and observational studies have indicated
that elevated total plasma homocysteine (tHcy) is an independent risk factor
for cardiovascular disease with risk increasing 40-60% for each 3-5 mol/L
increase in tHcy. However, clinical trials have failed to show reduction of
cardiovascular events with homocysteine lowering therapy. The B-vitamin
atherosclerosis intervention trial (BVAIT) assessed the impact on subclinical
atherosclerosis, in a population presumably free of cardiovascular disease, of
reducing total plasma homocysteine with B-vitamin supplementation.
This was a randomized double-blind placebo controlled trial con-
ducted from November 2000 to June 2006. Subjects were men and post-
menopausal women more than 40-years of age with fasting total homocys-
teine levels 8.5 mol/L. All subjects had no clinical signs or symptoms of
cardiovascular disease. Patients with diabetes, systolic blood pressures 160
mmHg, diastolic blood pressure  100 mmHg and creatinine clearance 
70 mL/min were excluded. There were 506 participants randomized to
high-dose of B-vitamin supplementation (5 mg folic acid  0.4 mg vitamin
B12  50 mg vitamin B6) or matching placebo for 3.1 years. Subclinical
atherosclerosis was assessed using carotid artery intima media thicknessvalues obtained with duplex scanning, the primary outcome measure. Mea-
surements of aortic and coronary artery calcification with multidetector
spiral CT scanning were secondary outcome measures. At follow-up there
was no statistical significant difference in the primary or secondary outcomes
comparing the patients with B-vitamin supplementation to those treated
with the placebo. A post-hoc analysis showed that subjects with baseline
tHcy’s  9.1 mol/L and randomized to B-vitamin supplementation had
statistically significant lower average rates of carotid intima media thickness
progression compared to the placebo group, p  0.02. Subjects with
baseline total homocysteines  9.1 mol/L had no treatment effect.
Comment: The authors contend that despite this being a post-hoc
analysis, their findings that vitamin-B supplementation can decrease carotid
intemia media thickness in individuals with fasting total homocysteine 9.1
mol/L is “highly relevant”. Perhaps this is true for the basic biology of
atherosclerosis but it is unlikely to have any clinical effect. Patients who had
decreases in carotid intimamedia thickness were an average age of 61-years and
had no signs of cardiovascular disease, no decrease in cardiovascular events, and
“benefitted” only by reduction in a subclinical marker of atherosclerosis. The
public health impact of these findings is likely to be nothing.
High Risk of Early Neurologic Recurrence in Symptomatic Carotid
Stenosis
Ois A, Cuadrado-Godia E, Rodriguez-Campello A, et al. Stroke 2009;40:
2727-31.
Conclusion: Patients with first mild stroke or TIA and significant
carotid stenosis are at high risk for neurologic recurrence, especially within
the first 72 hours of presentation.
Summary: Data from sub analysis of the European Carotid Surgery
Trial and the North American Symptomatic Carotid Endarterectomy Trial
have been evaluated to assess the risk of early stroke, defined as within two
weeks, after TIA or a mild stroke. These trials recruited only patients with
non-disabling stroke and therefore the number of patients who were not
included because of early recurrence or subsequent disability before time of
randomization is unknown. Recent studies have suggested a high recurrence
risk of neurologic events after a TIA or minor stroke (Stroke 2004; 35:2855-
2861, Brit Med J 2004; 328:326-328, and Neurology 2004; 62:569-573).
The authors of this paper sought to analyze recurrence risk for ischemic
events 72 hours, 7 days and 14 days in an unselected series of patients with
symptomatic,50% carotid stenosis and a first ever, non-disabling stroke or
TIA evaluated within the first 6 hours from onset of symptoms. There were
163 patients evaluated. Of these, 121 had an initial mild stroke and 42 had
a TIA. All were evaluated within 6 hours from onset of symptoms at a tertiary
care hospital. Neurologic recurrence was defined as a new neurologic event
(TIA or stroke) or an increase of 4 points in the initial National Institutes of
Health Stroke Scale. Neurology recurrence rates were determined at 72
hours, 7 days and 14 days. Patients were defined as disabled from their stroke
if they had a Rankin scale at 14 days of 3 to 6.
There were 45 patients (27.6%) that had a new neurologic event. Six
patients had two episodes at different time periods. Thirty-four events
(20.9%) occurred within the first 72 hours; 11 events (6.9%) occurred
between 72 hours and 7 days, and 6 events (3.7%) occurred at 14 days.
Carotid stenosis of 70% was associated with neurologic occurrence. Dia-
betes was marginally associated. At 2 weeks there were 19 patients (11.7%)
who had disability. Fourteen of these 19 patients had experience neurologic
recurrence within the first 72 hours.
Comment: Traditionally surgeons have been reluctant to intervene
acutely in a patient with a new stroke. In this study, however, only 2 patients
experienced non-disabling neurologic recurrence beyond 72 hours of symp-
toms. The results suggest the necessity of testing pharmacologic or inter-
ventional strategies to use in the hyperacute phase in patients with their
first-ever TIA or non-disabling stroke. Uurgent endovascular/surgical pro-
cedures in the first hours following presentation, which is clearly accepted in
other vascular pathologies such as coronary disease, needs to be evaluated in
a rigorous fashion in patient with acute neurologic events.
Multiligamentous Injuries of the Knee and Associated Vascular Injuries
McDonough EB, Wojtys EM. Am J Sports Med 2009;37:156-9.
Conclusion: Physical examination alone is not sufficient to detect the
majority of vascular surgery injuries after suspected knee dislocation.
Summary: The rate of injury to the popliteal artery from knee disloca-
tion varies widely from 7 to 80%. Evaluation of a patient with multiligament
damage of the knee and/or knee dislocation for the presence of vascular
injury is somewhat controversial. Traditionally, routine arteriography had
been advocated but more recently elective arteriography basing the decision
to proceed on arteriography on an abnormal physical examination or an
abnormal ankle-brachial index has been advocated. The authors sought to
report the frequency of vascular injuries in their patients with multiligament
injured knees and examine the role of arteriography in their treatment
protocol. This was a retrospective analysis of 71 patients over a 12 year
period of patients who had a diagnosis of multiligamentous injury of the
